Key clinical dimensions, including sensory gain, sensory loss, peripheral and central pain generators, mixed nociceptive‐neuropathic pain, central sensitization, and autonomic or small‐fiber modifiers are described, which support a shift from symptom‐based assessment to mechanism‐guided precision care for neuropathic p...
Y. Dai, Meng-Quan Tan, Man Yuan et al.· MedComm· 0 citations
Copeptin is a clinically relevant biomarker for early diagnosis and prognostic assessment of acute myocardial infarction (AMI). Traditional antibody-based assays suffer from long testing time, high cost and complicated operation. Herein, we first screened high-affinity copeptin aptamers under serum-mimicking conditions...